Brokers Offer Predictions for Enovix FY2026 Earnings

Enovix Co. (NASDAQ:ENVXFree Report) – Investment analysts at Northland Capmk issued their FY2026 earnings estimates for shares of Enovix in a note issued to investors on Friday, November 22nd. Northland Capmk analyst G. Richard expects that the company will post earnings per share of ($0.65) for the year. The consensus estimate for Enovix’s current full-year earnings is ($1.17) per share.

Enovix (NASDAQ:ENVXGet Free Report) last issued its earnings results on Tuesday, October 29th. The company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.03. The firm had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. During the same quarter in the prior year, the business earned ($0.27) earnings per share.

ENVX has been the topic of several other reports. Canaccord Genuity Group upped their price target on Enovix from $17.00 to $20.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Piper Sandler reaffirmed an “overweight” rating and set a $19.00 target price (down from $23.00) on shares of Enovix in a research report on Monday, August 5th. JPMorgan Chase & Co. lowered their price target on Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Craig Hallum upped their price objective on shares of Enovix from $15.00 to $20.00 and gave the company a “buy” rating in a report on Thursday, August 1st. Finally, Benchmark reaffirmed a “buy” rating and issued a $25.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $20.50.

Check Out Our Latest Stock Report on Enovix

Enovix Trading Up 3.6 %

NASDAQ ENVX opened at $9.43 on Monday. The company has a market capitalization of $1.68 billion, a price-to-earnings ratio of -5.86 and a beta of 1.99. Enovix has a one year low of $5.70 and a one year high of $18.68. The company has a debt-to-equity ratio of 0.99, a quick ratio of 3.61 and a current ratio of 3.77. The company’s 50-day simple moving average is $10.01 and its two-hundred day simple moving average is $11.31.

Institutional Trading of Enovix

Hedge funds have recently modified their holdings of the stock. Driehaus Capital Management LLC raised its position in Enovix by 63.7% during the second quarter. Driehaus Capital Management LLC now owns 3,886,492 shares of the company’s stock valued at $60,085,000 after acquiring an additional 1,512,424 shares in the last quarter. Fred Alger Management LLC grew its stake in shares of Enovix by 2,468.6% during the 3rd quarter. Fred Alger Management LLC now owns 588,614 shares of the company’s stock worth $5,498,000 after purchasing an additional 565,698 shares during the period. Old West Investment Management LLC increased its holdings in shares of Enovix by 47.6% during the 2nd quarter. Old West Investment Management LLC now owns 835,386 shares of the company’s stock valued at $12,915,000 after purchasing an additional 269,371 shares in the last quarter. Sora Investors LLC lifted its stake in shares of Enovix by 75.0% in the 3rd quarter. Sora Investors LLC now owns 525,000 shares of the company’s stock valued at $4,904,000 after purchasing an additional 225,000 shares during the period. Finally, Barclays PLC boosted its holdings in Enovix by 376.9% during the third quarter. Barclays PLC now owns 252,012 shares of the company’s stock worth $2,353,000 after buying an additional 199,166 shares in the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Insider Buying and Selling at Enovix

In other Enovix news, insider Arthi Chakravarthy sold 35,000 shares of Enovix stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $13.00, for a total transaction of $455,000.00. Following the completion of the transaction, the insider now owns 343,305 shares in the company, valued at approximately $4,462,965. This trade represents a 9.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 15.70% of the company’s stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Read More

Earnings History and Estimates for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.